the effect of cilazapril , a new inhibitor of angiotensin-converting enzyme , in a dosage of 2.5 or 5 mg once daily , was compared with that of hydrochlorothiazide 25 or 50 mg in 169 patients with mild to moderate hypertension .
C0020261
hydrochlorothiazide
C0020538
hypertension